Packaging Coordinators, Inc. (PCI) has reached a definitive agreement to acquire Penn Pharmaceutical Services Limited, a pharmaceutical services company headquartered in Tredegar, Wales with regional offices in New Hope, Pennsylvania and Tokyo, Japan.Penn Pharma offers both development and manufacturing services, including clinical and commercial dosage form manufacturing, as well as clinical packaging, labeling, and global storage, distribution and return drug services.

Recently, Penn Pharma opened purpose-built contained manufacturing facility in response to market need for specialist containment solutions for the development and manufacturing of solid oral dose products containing highly potent compounds. In 2014, Penn launched a capacity expansion project for large- scale commercial manufacturing and packaging.

PCI has announced several key investments recently, including cold-chain infrastructure expansions for both storage and logistics as well as support for refrigerated packaging operations. PCI will also open a 97,000-square foot North American storage and distribution facility for investigational products in September of this year.

PCI is principally owned by Frazier Healthcare, with partner investors QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners. Frazier Healthcare, founded in 1991 to invest exclusively in healthcare, is a provider of growth equity and venture capital to high growth and emerging healthcare companies.

Source: PCI